news_6

MEI Pharma and Kyowa Kirin Announce Publication in The Lancet Oncology of Data from Phase 1b Clinical Study of Zandelisib in Patients with Relapsed or Refractory B-cell Malignancy

SAN DIEGO & TOKYO--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer,...

logo-83

India EV Charging Equipment Market Outlook Report 2022-2026: Increasing Adoption of Electric Vehicles Along With Implementation of Fame II Policy by Government – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India EV Charging Equipment Market Outlook to FY'2026 - Driven by Increasing Adoption of Electric Vehicles Along With...